drugset / Trial / NCT01225341
Botulinum Toxin A for Herpes Labialis
RandomizedCrossoverDouble-blindPrevention
Summary
The purpose of this study is to determine the efficacy and safety of Botulinum Toxin Type A as a preventative measure for Herpes Labialis.
Timeline
- Start
- 2010-08
- Primary completion
- 2012-05
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 8 iu | Intramuscular |